“A tree is best measured when it is down,” the poet Carl Sandburg once observed, “and so it is with people.” The recent death of Harry Belafonte at the age of 96 has prompted many assessments of what this pioneering singer-actor-activist accomplished in a long and fruitful life.
Belafonte’s career as a ground-breaking entertainer brought him substantial wealth and fame; according to Playbill magazine, “By 1959, he was the highest paid Black entertainer in the industry, appearing in raucously successful engagements in Las Vegas, New York, and Los Angeles.” He scored on Broadway, winning a 1954 Tony for Best Featured Actor in a Musical – John Murray Anderson's Almanac. Belafonte was the first Black person to win the prestigious award. A 1960 television special, “Tonight with Belafonte,” brought him an Emmy for Outstanding Performance in a Variety or Musical Program or Series, making him the first Black person to win that award. He found equal success in the recording studio, bringing Calypso music to the masses via such hits as “Day-O (The Banana Boat Song)” and “Jamaica Farewell.”
Harry Belafonte - Day-O (The Banana Boat Song) (Live)www.youtube.com
Belafonte’s blockbuster stardom is all the more remarkable for happening in a world plagued by virulent systemic racism. Though he never stopped performing, by the early 1960s he’d shifted his energies to the nascent Civil Right movement. He was a friend and adviser to the Reverend Doctor Martin Luther King, Jr. and, as the New York Times stated, Belafonte “put up much of the seed money to help start the Student Nonviolent Coordinating Committee and was one of the principal fund-raisers for that organization and Dr. King’s Southern Christian Leadership Conference.”
The Southern Poverty Law Center notes that “he helped launch one of Mississippi’s first voter registration drives and provided funding for the Freedom Riders. His activism extended beyond the U.S. as he fought against apartheid alongside Nelson Mandela and Miriam Makeba, campaigned for Mandela’s release from prison, and advocated for famine relief in Africa.” And in 1987, he received an appointment to UNICEF as a goodwill ambassador.
Over a career spanning more than seventy years, Belafonte brought joy to millions of people. He also did something that is, perhaps, even greater: he fostered the hope that a better world for all could be created. And, by his example, demonstrated how we might go about bringing that world into existence.
Johnson & Johnson Issues Highlight How Incredibly Safe All the Vaccines Are
The risk of blood clots is so low it should actually make us feel safer.
This week the FDA and the CDC recommended a pause in the administration of Johnson & Johnson's single dose Covid-19 vaccine, after some recipients experienced life threatening blood clots.
While the pause is likely to be lifted within the next couple days — as officials investigate the issue to determine best practices moving forward, that hasn't stopped people from reacting like it's just been revealed that their baby powder contains asbestos.
Existing fears over the safety of the vaccines — which have been rumored to contain Bill Gates microchips, zombifying prions, or some sort of slow-acting execution serum — have sadly been bolstered and amplified. And many have been reacting as though this is a nail in the coffin for America's third-tier vaccine — which already suffered from unflattering comparisons to the higher efficacy rates of Pfizer and Moderna's two-dose options.
But that's not really the case. And closer examination of the issue reveals how much caution officials are exercising and how incredibly safe and effective all the vaccines actually are.
Dr. Anthony Fauci addresses J&J vaccine pause — 'This is a very rare event'www.youtube.com
While it's true that Johnson & Johnson's vaccine has shown a significantly lower efficacy in fully preventing COVID infections — 66-72%, compared to Pfizer and Moderna's 93-95% — all three vaccines share another, much more important figure: 100%. In studies, that's how effective they all were in preventing hospitalizations and deaths from COVID.
And while even a mild case of COVID can be spread to others, the chances are substantially reduced. The overall stats for Johnson & Johnson's vaccine would be considered phenomenal for an annual flu vaccine — let alone for a disease that was unheard of two years ago.
It's honestly incredible how quickly researchers around the world were able to collaborate in developing any vaccine at all, let alone run multiple versions through rigorous safety protocols. But they did; and as a result, cases of serious complications like this are incredibly rare.
Johnson & Johnson's vaccine alone would be considered miraculous if not for the existence of slightly better options. But — seeing as there are better options — is a Johnson & Johnson shot really worth the risk?
That depends on the person. But for most people, the correct response is, "What risk?" Of the 6.8 million Americans who have received the Johnson & Johnson vaccine, only six cases of these frightening blood clots have been recorded — all in women under the age of 50.
While these cases are all frightening — particularly the death of one Virginia woman — they represent less than 1 in a million vaccine recipients. While recent recipients are recommended to look out for symptoms, including severe headaches and shortness of breath, there's not even a clear indication of a causal relationship. In other words, it could all be a sad coincidence in which six women just happened to get some nasty blood clots within two weeks of receiving their shots.
Considering that positively identified COVID-19 cases have had a 1.8% mortality rate in the US — and around 1 in 600 Americans have already died as a result — that "possibly-1-in-a-million chance of developing blood clots that could kill you or not" seems like a pretty reasonable risk. The fact that it's a story at all just points to the overall safety of these treatments.
In this context, it's no wonder Europe is still planning to start administering Johnson & Johnson vaccinations, with officials from the EU's European Medicines Agency stating that "the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects." The only reason for a brief pause is to operate with an abundance of caution and for officials to adjust their recommendations for who should receive which vaccine.
Rather than recommending that everyone rush to get whatever option is most accessible, they may recommend that pre-menopausal women receive the Pfizer or Moderna shots. Or it could be far more specific — possibly related to an interaction with one or multiple types of contraceptive pill, which are already known to increase the risk of blood clots.
All-in-all, the frightening news about a vaccine possibly killing a woman is not nearly as frightening as the prospect that this incredibly rare case will feed into so-called "vaccine hesitancy". With around 20% of Americans in a recent survey still saying that they do not want to be vaccinated, and an additional 17% operating on a "wait and see" basis, we already face a monumental task in pushing for the all-important 70-90% herd immunity.
Herd Immunity and Coronavirus: Can It Be Achieved?www.youtube.com
Once we reach that ballpark, it will finally — finally — be possible to return to normal activities without the valid fear of contracting and spreading a wildly contagious and deadly virus. But that's going to take the work not only of manufacturing, distributing, and administering the vaccines, but of convincing those still on the fence of how important it is for everyone that they get immunized.
Sensationalizing a story about a small handful of scary cases and one death — compared to the hundreds of thousands of deaths the Johnson & Johnson vaccine is likely to prevent — is not going to help us get there. Instead, we should all take this opportunity to recognize what this story truly reveals: how careful health officials are being, and how remarkably safe the vaccines actually are.
3 Things You Should Know About The COVID-19 Vaccine
In all honesty, some level of skepticism about the COVID-19 vaccine is warranted. As a country, we've never experienced a situation such as this. In recent history, there has never been a virus as deadly and contagious as COVID-19. Moreover, there has never been a vaccine developed at such a swift rate.
That's why we're here to break down all of the pros and cons of the COVID-19 vaccine to help you make the most informed decision. It's your health we're talking about, after all, it shouldn't be taken lightly.
1. It doesn't contain the actual virus
First off, let's discuss what's inside of the COVID-19 Vaccine. As it stands, all COVID-19 Vaccines that currently exist are messenger RNA vaccines, or mRNA vaccines. mRNA vaccine technology has been studied for decades with a focus on other viruses such as the flu, rabies, and even Zika.
One benefit of mRNA vaccines is that scientists have the ability to apply a standardized mRNA "template" to new vaccines as new viruses are discovered. This means that scientists can tailor the mRNA vaccine to an individual virus to create vaccines at a rapid pace!
But how does it work? First off, mRNA vaccines contain strands of mRNA that function as a sort of instruction manual within the body. In the instance of COVID-19, these instructions tell the body how to create a fragment of the "spike protein" unique to SARS-CoV-2, the virus that causes COVID-19. Since mRNA encodes only for spike protein (which is a harmful protein found on the surface of the actual virus), the vaccine itself cannot cause a COVID-19 infection.
2. There are very few side effects if any, and the ones reported are extremely mild
Generally, any side effects reported as a result of taking the COVID-19 vaccine were reactogenicity symptoms. This means that nearly all symptoms were mild to moderate and would dissipate after only a few days. These side effects include pain, swelling, and redness in the area where you are vaccinated (common for any shot), as well as chills, fatigue, and headaches which should also go away in a day or two. It's important to note that these side effects are more common after the second dose of the vaccine.
But what about the more severe side effects that have popped up in the news cycle? Each of these can be considered one-off occurrences as they are not above the rate expected in the general population. In fact, many of these reported side-effects are simply unrelated to the vaccine as these cases tend to pop up sporadically every single year. When comparing the rate of these cases over the last month to the same period last year, there is no data that suggests that these cases are statistically significant. As such, there is no scientific link between the COVID-19 vaccine and any of these harmful side-effects.
3. The development process was not rushed as it went through full regulatory and safety review
One of the biggest fears behind the COVID-19 vaccine comes from the rapid pace at which it was developed and tested in clinical trials. However, relative to previous vaccine R&D, the COVID-19 vaccine was actually developed at a controlled pace. Right from the get-go, several of the biggest pharmaceutical companies signed a pact that stated that corners wouldn't be cut in an effort to be first to market. But if we're being honest, people don't really trust Big Pharma companies, and for good reason. There's an extensive history of big Pharma cutting corners and exploiting others to make a profit.
The important thing to note here is that you don't necessarily have to trust Big Pharma to trust the safety of the COVID-19 vaccine. First off, all results from clinical trials are available online and show comprehensive testing for each stage of the development process. In reality, the fast-tracking of the vaccine was the sole result of upfront financing provided by the federal government to ensure that no shortcuts were taken.
In essence, the government paid for vaccines to be mass-produced without knowing whether or not they worked. While this can be interpreted as a waste of funds, it also means that the time between final trials and the first delivery of a vaccine (which can often take months from production to distribution) was basically cut out of the equation. This accounts for why the vaccine was able to be developed, tested, manufactured, and distributed at an unparalleled rate.
3 Things You Should Know About The COVID-19 Vaccine
In all honesty, some level of skepticism about the COVID-19 vaccine is warranted. As a country, we've never experienced a situation such as this. In recent history, there has never been a virus as deadly and contagious as COVID-19. Moreover, there has never been a vaccine developed at such a swift rate.
That's why we're here to break down all of the pros and cons of the COVID-19 vaccine to help you make the most informed decision. It's your health we're talking about, after all, it shouldn't be taken lightly.
1. It doesn't contain the actual virus
First off, let's discuss what's inside of the COVID-19 Vaccine. As it stands, all COVID-19 Vaccines that currently exist are messenger RNA vaccines, or mRNA vaccines. mRNA vaccine technology has been studied for decades with a focus on other viruses such as the flu, rabies, and even Zika.
One benefit of mRNA vaccines is that scientists have the ability to apply a standardized mRNA "template" to new vaccines as new viruses are discovered. This means that scientists can tailor the mRNA vaccine to an individual virus to create vaccines at a rapid pace!
But how does it work? First off, mRNA vaccines contain strands of mRNA that function as a sort of instruction manual within the body. In the instance of COVID-19, these instructions tell the body how to create a fragment of the "spike protein" unique to SARS-CoV-2, the virus that causes COVID-19. Since mRNA encodes only for spike protein (which is a harmful protein found on the surface of the actual virus), the vaccine itself cannot cause a COVID-19 infection.
2. There are very few side effects if any, and the ones reported are extremely mild
Generally, any side effects reported as a result of taking the COVID-19 vaccine were reactogenicity symptoms. This means that nearly all symptoms were mild to moderate and would dissipate after only a few days. These side effects include pain, swelling, and redness in the area where you are vaccinated (common for any shot), as well as chills, fatigue, and headaches which should also go away in a day or two. It's important to note that these side effects are more common after the second dose of the vaccine.
But what about the more severe side effects that have popped up in the news cycle? Each of these can be considered one-off occurrences as they are not above the rate expected in the general population. In fact, many of these reported side-effects are simply unrelated to the vaccine as these cases tend to pop up sporadically every single year. When comparing the rate of these cases over the last month to the same period last year, there is no data that suggests that these cases are statistically significant. As such, there is no scientific link between the COVID-19 vaccine and any of these harmful side-effects.
3. The development process was not rushed as it went through full regulatory and safety review
One of the biggest fears behind the COVID-19 vaccine comes from the rapid pace at which it was developed and tested in clinical trials. However, relative to previous vaccine R&D, the COVID-19 vaccine was actually developed at a controlled pace. Right from the get-go, several of the biggest pharmaceutical companies signed a pact that stated that corners wouldn't be cut in an effort to be first to market. But if we're being honest, people don't really trust Big Pharma companies, and for good reason. There's an extensive history of big Pharma cutting corners and exploiting others to make a profit.
The important thing to note here is that you don't necessarily have to trust Big Pharma to trust the safety of the COVID-19 vaccine. First off, all results from clinical trials are available online and show comprehensive testing for each stage of the development process. In reality, the fast-tracking of the vaccine was the sole result of upfront financing provided by the federal government to ensure that no shortcuts were taken.
In essence, the government paid for vaccines to be mass-produced without knowing whether or not they worked. While this can be interpreted as a waste of funds, it also means that the time between final trials and the first delivery of a vaccine (which can often take months from production to distribution) was basically cut out of the equation. This accounts for why the vaccine was able to be developed, tested, manufactured, and distributed at an unparalleled rate.
Is the COVID-19 Vaccine Safe?
This is an extraordinary scientific achievement, but is it safe?
The average vaccine takes approximately 10 years to develop. There are currently two COVID-19 vaccines (Pfizer/BioNTech and Moderna) that will likely be authorized and released to the public within a year of the discovery of the virus. How can a safe vaccine possibly be developed so fast?
These will be the fastest vaccines ever developed, by a margin of years. The next fastest vaccine ever approved for public use was the mumps vaccine, and that took 4 years.
Unfortunately, that speed has made a lot of people nervous. Will the vaccine be safe? Are they skipping steps? How is this process moving so fast?
According to Pew Research, 77% of Americans think it's very or somewhat likely a COVID-19 vaccine will be approved in the United States before its safety and effectiveness are fully understood.
But regardless of the fear and doubt, we need a vaccine. We are now losing over 2,000 American lives per day to COVID-19. Numerous health experts have warned that this pandemic will not truly be over until we have a vaccinated population.
Part of the fear is related to the mystery surrounding the process of vaccine creation. Almost no one who isn't integrally involved in vaccine development understands how long it takes to create a vaccine or why it takes so long. So to most Americans speed doesn't seem like a feat of modern science, it seems like cutting corners. Here are all the (genuinely not scary) reasons why this vaccine is being developed so much faster than any in history.
Operation Warp Speed
Operation Warp Speed (OWS) is a coordinated government effort to defeat this virus as quickly as possible. It is a partnership between the Department of Defense and the Department of Health and Human services to make resources available to the private companies involved in creating vaccines, testing, and therapeutics for COVID-19. In practice, OWS has focused primarily on the creation of vaccines and has already spent billions ensuring that the vaccine development, manufacturing, and distribution process can move as efficiently as possible.
The US program is bankrolling the development and production of six promising coronavirus vaccine candidates. This has already sped up the process significantly and will likely play an even larger role in the manufacturing process. Medical research of any kind often moves slowly because it's expensive and risky.
Funding is hard to secure, because in order to prove a vaccine is successful (and therefore profitable) you have to have tests, and to do tests, you need money. It's sort of a catch-22 that is only ended when someone decides to make a risky bet.
Betting on vaccines is risky, because if it ends up being unsuccessful (the majority of vaccines never make it to market), that money is just gone. The US government chose to take the gamble.
The US has spent $10 billion through OWS on the most promising vaccine candidates, ensuring they don't have to wait for private funding to move through each phase of the process.
Combining Steps
Many people are concerned that these drug companies are skipping steps in the race to create a vaccine, but what's actually happening is that multiple steps in the process are being done simultaneously.
Steps that are usually done sequentially are being done at the same time. For example, some labs are running combined Phase 1 and Phase 2 human trials or having vaccine development manufacturing facilities ready even before a vaccine is finalized. This increases the financial risk, but not the product risk.
Typically, clinical trials set up their own independent panels of scientists, known as a data safety monitoring board or DSMB, to watch out for safety concerns or early signs of success. But all of the vaccine trials in Operation Warp Speed are sharing a common DSMB. This allows the DSMB to review the data from all the trials from the various vaccines concurrently. That shared data expedites the process and quickly identifies which vaccines are effective and which aren't without wasting time and resources.
Saad Omer, director of the Yale Institute of Global Health, explains that this is not a huge difference. "There's really just a subtle difference in how the trials are run. If the trials were separate, you would publish the full data, and then recruit a new set of participants. For a combined trial, the data and safety monitoring board would look at the interim data and determine whether it's still worth continuing the trial." This continuous monitoring cuts the inefficiencies out of the process without changing the safety standards.
Years of Prior Research
The research stage of vaccine development is often one of the longest. The College of Physicians of Philadelphia states that this exploratory phase "often lasts 2-4 years." Thankfully, much of the research needed for the COVID-19 vaccine had already been done before the novel coronavirus even appeared.
The term "coronavirus" includes a family of several known viruses that cause respiratory tract illnesses that range from the common cold to such potentially deadly illnesses as severe acute respiratory syndrome (SARS), which killed almost 800 people during an epidemic that occurred in 2002 and 2003. After the SARS outbreak, research on coronaviruses increased significantly. So when SARS-Cov-2 or COVID-19 appeared, vaccine work on some of its relatives had already been underway. This gave scientists a significant head start.
Another way in which scientists weren't exactly starting from scratch on this vaccine is thanks to the messenger RNA or mRNA technology. mRNA technology is a completely new vaccine technology that is being used in both the Pfizer/BioNTech vaccine and the Moderna vaccine. Both the Pfizer/BioNTech and Moderna vaccine use mRNA to trigger the immune system to produce protective antibodies without using actual samples of the virus.
While this mRNA science hasn't created a successful vaccine before now, the ideas behind an mRNA vaccine have been studied and tested extensively for over 30 years.
In the natural world, the body relies on millions of tiny proteins to keep itself alive and healthy, and it uses mRNA to tell cells which proteins to make. The concept behind an mRNA vaccine is simple: If you can design your own synthetic mRNA, you could tell the body to create whatever proteins you want, including antibodies to vaccinate against infection.
Messenger RNA vaccines are a game-changer in terms of speed. The mRNA vaccines produced by Pfizer/BioNTech and Moderna are faster to develop as they don't require companies to produce protein or weakened pathogens for the vaccine.
Traditional vaccines typically use a weakened version of the disease or a protein piece of it, but because these are grown in eggs or cells, developing and manufacturing vaccines takes a long time. In contrast, the genetic material mRNA is efficient to make, and highly customizable.
Short but Large Phase 3
When a new vaccine is tested on humans, it is tested in three phases. Each phase increases in size and scope. The length of study for phase 3 clinical trials is usually 1 to 4 years and normally involves 300 to 3,000 patients.
COVID-19 is killing over 2,000 Americans a day, so we don't have time to wait for a lengthy trial. To resolve this issue, they have increased the trial size significantly. Pfizer's phase 3 trial had 43,000 volunteers, and Moderna's had 30,000.
These are what are called "event-driven trials." Basically an event in this case is when one of the volunteers gets sick with COVID-19. Once a trial reaches a previously decided on number of events, they check how many of the people that got sick were given the real vaccine and how many were given the placebo. This shows how effective the vaccine actually was.
The incredibly large trial size and the prevalence of the disease has allowed the "events" to occur quickly, making it easy to test the efficacy of the vaccine. Normally clinical trials can be held back by low volunteer numbers and low disease prevalence. However, COVID-19 spreads rapidly and pretty much all adults seem to be susceptible, which makes these problems irrelevant.
The only downside of a shorter but larger trial is that you don't get to see what long-term effects the vaccine will have. But scientists agree that the chances of long-term complications are extremely unlikely because of how vaccines work. Deborah Fuller, Ph.D, who is a vaccine scientist with UW Medicine, explains, "Most of their job is done in the first few days, then the vaccine is gone from your body. So what's left is that immune response to the vaccine."
Emergency Use Authorization
At the end of the vaccine making process, when the trials are finished and the research is done, companies submit a Biologics License Application (BLA) to the FDA. The BLA usually takes about a year to gain approval. To speed up the process, COVID-19 vaccines are seeking an Emergency Use Authorization (EUA) before they are even done collecting data.
Under an EUA, a company can produce and distribute a vaccine that hasn't officially been approved. This is a process meant for one purpose: to save lives. The FDA will only grant an EUA if they believe that the expected benefits outweigh the possible risks of the vaccine.
Early in the pandemic, the FDA issued a list of requirements they would need from a company before they would consider issuing an EUA for a vaccine. Those guidelines included information about how many people had to be involved in trials, how long the follow up with them had to be, and what information had to be included in their reports.
To ensure that this EUA isn't about cutting corners, the FDA has appointed an independent advisory board to aid them in their decision about the vaccine. On Thursday this week the FDA is scheduled to convene a meeting of that advisory board, known as VRBPAC, to review Pfizer's Covid-19 vaccine for emergency use authorization.
This vaccine is coming, and it's coming quickly. At first that might seem scary, but in reality it's just a perfect confluence of events that have allowed scientific minds to do the impossible. Operation Warp Speed, years of usable research, combining steps, a differently designed phase 3, and emergency use authorizations have all come together to create the perfect situation to make a safe and effective vaccine—in record time.
For more well-researched, unbiased information on today's biggest issues, follow Alexandra's Instagram account The Factivists.
No Good Billionaires—Myth 3: Those Foundations Do a Lot of Good
Billionaires' private charities help them push personal agendas on the world—when they aren't just dodging taxes.
Don't you just love stories about people giving back?
While there's a lot of greed out there, some of the richest people on Earth realize how lucky they are and decide to share the wealth.
Just look at Jeff Bezos of Amazon and his decision to donate $100 million to food banks. It's a lot more than you and I (and several large families put together) will ever give to charity… Because it's more than we'll earn in our entire lifetimes.
It's more than you could fit in the trunk of your car in stacks of $100 bills! If you put it all in a basic savings account, you and me and those several families could all easily live off the interest alone!
Actually, when you think about it like that, it's kind of more money than any one person could ever need or even spend on anything normal...
Sure, if you want to travel the world in a luxury blimp, eating meals out of the skulls of dead celebrities, you could spend it all pretty easily. But if you're just trying to have a happy, comfortable life, $100 million isn't much better than an $80,000 salary.
Fixing the World's Problems
So why doesn't any of these mega-billionaires like Jeff Bezos, Michael Bloomberg, Elon Musk, or any one of the Walmart Waltons just give away their riches and go down in history as the person who ended world hunger? At an estimated cost of $20 billion a year, each of them could afford to end homelessness in America for between two and eight years.
They could even keep a few car trunks stuffed with hundreds so they could continue living like kings and hunting olympic athletes for sport. And imagine how much all those people could improve their lives if they had stable places to live and sleep.
It must not be that simple... Because if private greed was the only thing standing in the way of transformational change, governments could have collected all that wealth with some steep taxes and made the world a better place. There has to be some reasonable explanation for why these people don't just give it all away…
In this series we are looking at a number of prominent myths around philanthropy, including the notions that billionaires' "wealth" is substantially different than money, and that they are important patrons of the arts.
Previously we debunked the ideas that charity is better than "government handouts" and that it's even possible for billionaires to be generous, but today we'll look at the question of whether their private charitable foundations are powerful forces for good.
Myth: Those foundations do a lot of good though
The Myth: They might not be as good as well-funded government programs, but in the absence of the political will to raise taxes and establish those kinds of programs, the private charitable foundations of billionaires do a lot of good and are a great option for helping people in need.
Why It's Wrong: There's no doubt that some of those foundations have truly helped people in significant, life-changing ways. But, generally speaking, the stated charitable missions of these organizations are secondary to their function as tax havens.
Adam Ruins Everything - Why Billionaire Philanthropy is Not So Selfless | truTVwww.youtube.com
In the past these organizations were a useful way for anyone lucky enough to be leaving assets in excess of ~$600,000 to their loved ones to avoid the estate tax. These days the estate tax has been gutted to the benefit of no one who has ever earned anything, and the amount has been pushed above $11,000,000. But there are plenty of people who still want that loophole or enjoy the prestige that private charitable foundations provide them.
Often private LLCs directly controlled by the billionaire funders, these foundations allow for income not only to evade income tax, while earning the donor a tax deduction on top of that. Of course in order to qualify for these benefits, the organization must meet the requirements of a non-profit, but the standards aren't exactly strict.
What Billionaires Want
Not only can the organization focus only on the issues that matter most to a person with ungodly amounts of money (a cure for all the papercuts they get from flipping through their stacks?), they only need to spend 5% of their investment assets annually. And they could choose to spend that amount on administrative costs and salary for the friends/lackeys they've chosen to run them.
You basically have to be as blatantly self-serving and corrupt as Donald Trump—spending other people's money to buy a portrait of himself—to come under any real scrutiny, and even then it's only if you're running for president...
On top of that, these foundations are free to grow their assets through investments—even in for-profit industries that work in diametric opposition to the foundations' stated goals. Consider the fact that—until Bill Gates was publicly shamed into divesting—the Bill and Melinda Gates Foundation was heavily invested in fossil fuel companies.
Apart from their horrifying impact on climate change, these companies are among the worst offenders on Earth in terms of polluting fresh water resources. If only there was a charitable foundation that was focused on preserving and cleaning water supplies in developing countries. Like, for instance, the WASH program…of the Bill and Melinda Gates Foundation.
Worse still, many so-called charitable donations end up going to think tanks, university branches, and political advocacy groups that fund and promote research and policy initiatives that support the interests of the wealthy.
The effect is to amplify ideas that ultra-wealthy already believe and what they want to be true. If you were a researcher who had reason to believe that increasing the top marginal tax rate to 90% could solve all of our nation's most pressing problems, you would struggle to get your research funded. But if you managed to complete it and get it published, there would immediately be 10 well funded studies seeking to disprove it.
The Bill Gates Approach to "Fixing" Education
Look again at the Bill and Melinda Gates Foundation. Not only does it give a lot of money to so-called good causes that primarily serve the wealthy, but even when the foundation is focused on trying to do actual good they often end up hurting more than they help.
Among its primary focuses has been revamping America's public school systems, which has involved billions of dollars being spent on various initiatives to change the way teachers are trained, the way children are taught, and the way schools themselves are organized—all with an emphasis on data collection and standardized testing.
Among the complaints against how the Foundation operates is the fact that its model of reform and success involves little input from educators and that Bill Gates himself essentially steers the ship with little resistance from within the organization. And the results have been...less than stellar.
Obviously the goal of improving the education system for everyone is admirable, but the allure of Gates' money and his supposed genius has tempted state and local governments to match his initiatives with a lot of money of their own.
And time after time those initiatives have been abandoned as soon as they don't yield the results Gates was looking for—leaving schools and municipalities on the hook for cleaning up the mess without that financial backing.
From Common Core to smaller schools to creepy data mining, Gates' ideas have faltered or crumbled when they meet with the real world, and they've ended up costing the communities they "serve" a lot more than they've ever cost him. At this point you could argue that the biggest accomplishment the foundation has achieved is rehabilitating Bill Gates' predatory reputation.
But he is way too rich to be ashamed of his failures. So Bill Gates just keeps going and pushes his narrow-minded views on education even harder. These days he's helping New York Governor Andrew Cuomo with the idea that we don't even need classrooms…
Stricter Standards for "Charity"
So while claims that Bill Gates is using vaccines to spread the mark of the beast and practice eugenics are a bit wild, the work of these private charities definitely deserve more scrutiny.
Basically, even when these private foundations aren't glorified tax shelters, they're still awful. As well-intentioned as some billionaires might be, they are too powerful, too used to getting their way, and too detached from real life to actually be much use in helping people.
In other words, we need to make the standards for these foundations far stricter—to make sure they're doing some actual good in exchange for their tax evasion—and once we've done that, we need to tax the hell out of all the billionaires' money so they remember what it's like to be human.
And if you're thinking that we can't do that—because all that wealth is tied up in investments—we'll have to cover that myth in the next installment.